ESMO – Eur. Oncology, recently shared on X:
“ESMO 2026: You still have time to register and benefit from advantageous fees!
Join Yelena Janjigian, Scientific Committe e Co-Chair, for an extraordinary gathering of leading minds in oncology from around the globe.
Late registration deadline: 16 September 2026
Register here.”
Yelena Janjigian, Chief, Gastrointestinal Oncology at Memorial Sloan Kettering Cancer Center, added on X:
“Come to see this data!!
Title: Merck and Moderna Announce Phase 3 INTerpath-001 Trial of Intismeran Autogene Plus KEYTRUDA Met Endpoints of Recurrence-Free Survival (RFS) and Distant Metastasis-Free Survival (DMFS) in Patients With Completely Resected Stage IIB-IV Melanoma
Read The Full Data.”
Yelena Janjigian was recognized among OncoDaily’s The 100 Most Influential People in Oncology in 2025, highlighting his contributions to the field of oncology.
Nominations for 100 Influential People in Oncology 2026 are now open, recognizing leaders, researchers, clinicians, innovators, advocates, and other individuals making a meaningful impact on oncology and cancer care.
Don’t miss the opportunity to nominate yourself, a colleague, or someone whose contributions deserve to be recognized.
Submit your nomination by September 15: 100 Influential People in Oncology 2026 – Nominations are Open!
Other articles featuring Yelena Janjigian on OncoDaily.